Updated Jul 16, 2026
Swartz Robin is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $92K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-26 | VYGR | Voyager Therapeutics, Inc. | S — Open-market sale | 6.5K | $3.77 | $24K |
| 2026-02-20 | VYGR | Voyager Therapeutics, Inc. | S — Open-market sale | 3.9K | $3.44 | $13K |
| 2026-02-11 | VYGR | Voyager Therapeutics, Inc. | S — Open-market sale | 4.6K | $3.85 | $18K |
| 2026-02-10 | VYGR | Voyager Therapeutics, Inc. | A — Grant or award | 45.0K | $0.00 | |
| 2024-12-26 | VYGR | Voyager Therapeutics, Inc. | S — Open-market sale | 6.5K | $5.65 | $37K |
Swartz Robin is a corporate insider — currently tracked as COO & CBO. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($92K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Swartz Robin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.